TickerFacts.

Company research / IRTC

iRhythm Holdings, Inc. (IRTC)

Build a valuation ↗↓ Download CSV

CIK 0001388658 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, iRhythm Holdings, Inc. reported revenue of $747.14M. Revenue grew 26.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $825.34M.

Key ratios (year ended 2025-12-31)

70.6%
Gross margin
-7.7%
Operating margin
-6.0%
Net margin
-29.2%
Return on year-end equity
26.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-05

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$825.34M$747.14M$591.84M$492.68M$410.92M$322.82M$265.17M$214.55M$147.28M$99.13M$64.07M
Cost of Revenue$235.60M$219.89M$184.31M$160.88M$129.29M$109.26M$70.28M$52.48M$38.80M$28.20M$20.88M
Gross Profit$589.74M$527.25M$407.53M$331.81M$281.63M$213.57M$194.89M$162.07M$108.48M$70.93M$43.19M
R&D Expense$83.28M$84.61M$71.46M$60.24M$46.61M$38.67M$41.33M$37.30M$20.86M$13.27M$7.15M
Operating Income-$24.87M-$57.41M-$115.50M-$125.16M-$113.78M-$99.94M-$43.67M-$54.76M-$45.69M-$27.59M-$15.58M
Depreciation & Amortization$20.69M$20.74M$20.71M$16.35M$13.40M$9.84M$6.90M$3.44M$2.27M$1.60M$568.0K
EBITDA-$4.18M-$36.66M-$94.79M-$108.81M-$100.38M-$90.10M-$36.77M-$51.31M-$43.42M-$25.99M-$15.01M
Net Income-$13.95M-$44.55M-$113.29M-$123.41M-$116.16M-$101.36M-$43.83M-$54.57M-$50.38M-$29.74M-$20.90M
EPS (Diluted)n/a-$1.39-$3.63-$4.04-$3.88-$3.46-$1.58-$2.16n/an/an/a
Total Assets$1.09B$1.02B$931.45M$433.14M$448.22M$462.97M$511.74M$306.21M$117.52M$133.12M$138.16M
Total Liabilities$907.44M$867.30M$840.54M$223.05M$208.41M$183.45M$170.13M$170.80M$65.39M$53.57M$45.59M
Long-Term Debtn/an/an/an/an/a$9.69M$21.34M$32.99M$34.90M$44.78M$46.33M
Shareholders' Equity$185.98M$152.75M$90.91M$210.10M$239.81M$279.51M$341.61M$135.41M$52.14M$79.34M$92.56M
Cash & Equivalents$246.68M$236.01M$419.60M$36.17M$78.83M$127.56M$88.63M$20.46M$20.02M$8.67M$51.64M
Operating Cash Flow$86.00M$80.86M$3.39M-$50.10M-$23.01M-$37.75M-$13.76M-$21.86M-$29.09M-$14.91M-$16.65M
Capital Expenditures$47.02M$46.34M$33.94M$40.42M$29.83M$28.07M$13.55M$20.46M$5.18M$3.56M$2.76M
Free Cash Flow$38.98M$34.52M-$30.55M-$90.53M-$52.84M-$65.82M-$27.31M-$42.32M-$34.27M-$18.47M-$19.41M
Share Repurchasesn/a$0$25.00M$0$0n/an/an/an/an/an/a
Shares Outstanding32.94M32.30M31.39M30.95M30.19M29.49M29.02M26.68M24.37M23.38M22.14M
Weighted Average Diluted Sharesn/a32.00M31.20M30.53M29.92M29.33M27.75M25.27Mn/an/an/a
EPS (Basic)n/a-$1.39-$3.63-$4.04-$3.88-$3.46-$1.58-$2.16n/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView